Global Migraine Clinical Trial Pipeline Report 2021: Phase 3 Clinical trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Preclinical Research, and Discovery Stage - ResearchAndMarkets.com

·2 min read

The "Global Migraine Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Migraine Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Migraine market.

It covers emerging therapies for Migraine in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Migraine pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Migraine pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Migraine pipeline products by the company.

Short-term Launch Highlights:

Find out which Migraine pipeline products will be launched in the US and Ex-US till 2025.

SUMMARY:

  • Migraine phase 3 clinical trial pipeline products

  • Migraine phase 2 clinical trial pipeline products

  • Migraine phase 1 clinical trial pipeline products

  • Migraine preclinical research pipeline products

  • Migraine discovery stage pipeline products

  • Migraine pipeline products short-term launch highlights

Key Topics Covered:

1. Migraine Pipeline by Stages

2. Migraine Phase 3 Clinical Trial Insights

3. Migraine Phase 2 Clinical Trial Insights

4. Migraine Phase 1 Clinical Trial Insights

5. Migraine Preclinical Research Insights

6. Migraine Discovery Stage Insights

7. Appendix

8. Research Methodology

Countries Covered

  • Global

  • Europe

  • US

  • Germany

  • France

  • UK

  • Spain

  • Italy

  • Japan

For more information about this report visit https://www.researchandmarkets.com/r/34emqa.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210127005760/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Latest Stories

  • Fan cutouts at Women's Final Four to benefit Pat Summitt, Kay Yow funds

    Fans looking to get into the cardboard cutout game at the Women's Final Four will also benefit charities connected to icons of the game.

  • Peloton Expanding Into Australia

    Peloton Interactive (NASDAQ: PTON) is going Down Under to find a new source of growth. The exercise bike and online classes specialist announced Monday that it is expanding to Australia, for its initial toe-in-the-water into the Asia Pacific region. Australians wishing to get in shape and willing to fork over the money for Peloton's comparatively pricey goods will be able to buy both the Peloton Bike and the Peloton Bike+, the company's popular hardware items.

  • PayPal Acquiring Cryptocurrency Security Company Curv

    PayPal Holdings (NASDAQ: PYPL) is acquiring a new asset. The company announced Monday that it has agreed to purchase Curv, a privately held digital asset security specialist based in Israel. Curv focuses on security solutions (delivered via cloud computing) for the blockchain, the digital technology that is at the root of cryptocurrencies.

  • Japan downgrades fourth-quarter GDP as companies scale back spending

    The slower growth was mainly due to a sharper contraction in private inventories and capital expenditure expanding less than previously thought in the fourth quarter, even as exports remained solid. Separate data showed household spending was hit by a bigger annual drop in January than in the prior month, a sign the COVID-19 pandemic was keeping consumers cautious about shopping. Private inventories, including raw materials and manufactured products, subtracted 0.6 percentage point from revised growth domestic product growth (GDP), worse than a negative preliminary contribution of 0.4 percentage point.

  • Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Ebix, Inc.

    RADNOR, Pa., March 08, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Southern District of New York against Ebix, Inc. (NASDAQ: EBIX) (“Ebix”) on behalf of those who purchased or acquired Ebix securities between November 9, 2020 and February 19, 2021, inclusive (the “Class Period”). Investors who purchased or acquired Ebix securities during the Class Period may, no later than April 23, 2021, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435; toll free at (844) 887-9500; via e-mail at info@ktmc.com; or click https://www.ktmc.com/ebix-inc-securities-class-action-lawsuit?utm_source=PR&utm_medium=link&utm_campaign=ebix Ebix supplies infrastructure exchanges to the insurance, financial, travel, cash remittances, and healthcare industries. The Class Period commences on November 9, 2020, when Ebix filed its quarterly report for the period ended September 30, 2020 on a Form 10-Q with the SEC, stating in relevant part that the “Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our ‘disclosure controls and procedures’ . . . [and] have concluded that these disclosure controls and procedures are effective.” On February 19, 2021, after the market closed, Ebix revealed that its independent auditor, RSM US LLP (“RSM”), resigned “as a result of being unable, despite repeated inquiries, to obtain sufficient appropriate audit evidence that would allow it to evaluate the business purpose of significant unusual transactions that occurred in the fourth quarter of 2020” related to Ebix’s gift card business in India. RSM also stated that there was a material weakness related to Ebix’s failure to design controls “over the gift or prepaid card revenue transaction cycle sufficient to prevent or detect a material misstatement.” Additionally, Ebix and RSM disagreed over the accounting treatment of $30 million that had been transferred into a commingled trust account of Ebix’s outside legal counsel in December 2020. Following this news, Ebix’s share price fell $20.24, or approximately 40%, to close at $30.50 on February 22, 2021. The complaint alleges that, throughout the Class Period, the defendants failed to disclose to investors that: (1) there was insufficient audit evidence to determine the business purpose of certain significant unusual transactions in Ebix’s gift card business in India during the fourth quarter of 2020; (2) there was a material weakness in Ebix’s internal control over the gift or prepaid revenue transaction cycle; (3) Ebix’s independent auditor, RSM, was reasonably likely to resign over disagreements with Ebix regarding $30 million that had been transferred into a commingled trust account of Ebix’s outside legal counsel; and (4) as a result of the foregoing, the defendants’ positive statements about Ebix’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Ebix investors may, no later than April 23, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com. CONTACT: Kessler Topaz Meltzer & Check, LLPJames Maro, Jr., Esq.Adrienne Bell, Esq.280 King of Prussia RoadRadnor, PA 19087(844) 887-9500 (toll free)info@ktmc.com

  • ‘Bachelor’ recap Week 10: From ‘fantasy’ dates to a real (tense) talk with dad

    Raleight native Matt James has talked about being raised by a single mom. Tonight, he confronts his dad about why he left the family.

  • Oil prices rise on expected economic recovery, likely drawdown in oil stocks

    Oil prices rose on Tuesday on expectations of a recovery in the global economy after U.S. Senate approval of a $1.9 trillion stimulus bill and on a likely drawdown in crude oil inventory in the United States. But a stronger dollar and receding fears of oil supply disruption from Saudi Arabia after an attack on its oil facilities capped price gains. Brent crude futures for May rose by 32 cents, or 0.5%, to $68.56 a barrel by 0125 GMT, while U.S. West Texas Intermediate (WTI) crude for April rose 19 cents, or 0.3%, to $65.24.

  • Dak Prescott just became the Dallas Cowboys’ new Danny White and Tony Romo | Opinion

    The burden of expectation for Dak is clear: be Roger or Troy, and not another Danny or Tony.

  • Former Canadian major-leaguer Rheal Cormier dies after battle with cancer

    Canadian pitcher Rheal Cormier, who spent 16 years in the major leagues, died Monday after a battle with cancer. The native of Moncton, N.B. was 53. The Philadelphia Phillies, one of Cormier's former teams, confirmed his passing. "We are saddened to learn of the passing of former relief pitcher Rheal Cormier after a courageous battle with cancer," the club tweeted. The Canadian Baseball Hall of Fame says Cormier ranks second all-time for games pitched by a Canadian with 683. “I am shocked and saddened to learn of Rheal’s passing,” said Baseball Canada president Jason Dickson. “He was a tremendous pitcher and competitor who represented our country on the biggest stage. Above all, Rheal was a great person and family man who will be dearly missed.” A sixth-round pick by the St. Louis in 1988, Cormier broke into the big leagues with the Cardinals three years later. After being traded to Boston (1995), Cormier was shipped to the Montreal Expos in 1996. Cormier spent two years with Montreal before finishing his major-league career with Boston (1999-2000), Philadelphia (2001-06) and Cincinnati (2006-07). For his career, Cormier was 71-64 with a 4.03 earned-run average. Cormier's best year was 2003 with Philadelphia when he was 8-0 as a reliever with a 1.70 ERA. According to the Phillies, that was the second-lowest among relievers and sixth-lowest by any club reliever in the modern era (since 1900). Cormier made 84 appearances the following season, the most ever by a left-handed Philadelphia pitcher. The franchise said in a statement it was also the second-most among any pitcher and remains the most logged in a year by a Phillies player in the last 33 seasons. During his tenure in Philadelphia, Cormier appeared in 363 games as a reliever. It's the second-most in club history behind Tug McGraw and fourth-most of any relief pitcher. Cormier was also active in the community while with the Phillies. According to the team, he contributed regularly to Phillies Charities Inc. and visited area hospitals. And during his time with Montreal, Cormier was involved with many New Brunswick school programs and served as a spokesman for teenage anti-suicide and anti-drug campaigns. "Rheal was one of the most vibrant people I’ve had the pleasure of knowing," Jim Thome, a former teammate of Cormier's in Philadelphia and friend, said in a statement. "He loved baseball, but he always put his family first. "(Cormier) was the kind of guy who would do anything for you and I'm lucky to have called him my friend for many years. Our time spent together in Philadelphia as teammates was unforgettable. He will be greatly missed but never forgotten." Cormier also represented Canada at the 1987 Pan American Games, the 1988 and 2008 Olympics and the 2006 World Baseball Classic. He became an American citizen in 2004 and was inducted into the Canadian Baseball Hall of Fame in 2012. "Not only was he was one of the greatest major league relief pitchers ever to come from Canada, but he was a wonderful and charismatic guy who was proud of his Canadian roots and loved his family deeply," Scott Crawford, the Canadian Baseball Hall of Fame's director of operations," said in a statement. Cormier is survived by his wife Lucienne (nee LeBlanc), son Justin and daughter Morgan. Funeral arrangements are pending. This report by The Canadian Press was first published March 8, 2021. The Canadian Press

  • Texas lieutenant governor calls on power grid operator to correct $16 billion pricing error

    Potomac Economics, the independent market monitor for Texas power regulator the Public Utility Commission, said last week that ERCOT made a $16 billion pricing error as it kept market prices charged to electricity providers too high for more than a day after widespread outages ended late on Feb. 17. "Correcting this $16 billion error will require an adjustment, but it is the right thing to do," Patrick said in a statement on Monday.

  • Teen Vogue Staffers Express Concerns Over New Top Editor

    Alexi McCammond's past racist and homophobic tweets were unearthed over the weekend.

  • Oprah Winfrey reprised 'Big Event TV' with Harry and Meghan interview

    The two-hour extravaganza on CBS demonstrated the power of broadcast TV -- and Oprah Winfrey.

  • RRSP Investors: 3 Best Dividend Stocks to Buy Today

    RRSP investors should target dividend stocks like Manulife Financial Corporation (TSX:MFC)(NYSE:MFC) in early March. The post RRSP Investors: 3 Best Dividend Stocks to Buy Today appeared first on The Motley Fool Canada.

  • Del Taco Restaurants Inc (TACO) Q4 2020 Earnings Call Transcript

    TACO earnings call for the period ending December 29, 2020.

  • Shoppers Love Chrissy Teigen’s Secret Weapon for ‘Amplified’ Lips

    “If you have lips like me, this is bomb”

  • Astros boost rotation by signing Odorizzi to 2-year deal

    HOUSTON — Right-hander Jake Odorizzi signed a two-year contract with the Houston Astros on Monday. An All-Star with Minnesota in 2019, Odorizzi was limited to four starts last season because of injuries. He was 0-1 with a 6.59 ERA for the Twins during the pandemic-shortened 2020 season. Odorizzi was selected to his first All-Star team in 2019 when he made 30 starts and went a career-best 15-7 with a 3.51 ERA. He had 178 strikeouts and allowed 139 hits that season for the Twins. He’ll join an Astros rotation that entered this year without ace Justin Verlander, who is recovering from Tommy John surgery, and lost Framber Valdez indefinitely to a broken finger this spring. The 30-year-old Odorizzi spent the last three seasons with the Twins and has also pitched for Tampa Bay and Kansas City during his nine-year career. He is 62-56 with a 3.92 ERA in 195 appearances (192 starts). He’s won at least 10 games four times and has four seasons with at least 30 starts. Houston placed reliever Pedro Báez on the injured list to make roster room for Odorizzi. ___ More AP MLB: https://apnews.com/MLB and https://twitter.com/AP_Sports The Associated Press

  • 9-1-1 Boss on Hen's Heartbreak, Buck's Breakthrough and More in Winter Finale

    Monday’s 9-1-1 winter finale certainly lived up to its title, with several characters being pushed to a “Breaking Point.” For Hen, that came when Mia’s social worker showed up to inform her and Karen that Mia’s biological mother is ready to begin the reunification process. It was quite literally the foster moms’ worst fear come […]

  • ROSEN, A LEADING LAW FIRM, Encourages Tyson Foods, Inc. Investors With Large Losses to Secure Counsel Before Important Deadline – TSN

    NEW YORK, March 08, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tyson Foods, Inc. (NYSE: TSN) between March 13, 2020 and December 15, 2020, both dates inclusive (the “Class Period”), of the important April 5, 2021 lead plaintiff deadline in the securities class action first filed by the firm. SO WHAT: If you purchased Tyson securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Tyson class action, go to http://www.rosenlegal.com/cases-register-2022.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. If you wish to serve as lead plaintiff, you must move the Court no later than April 5, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Tyson knew, or should have known, that the highly contagious coronavirus was spreading throughout the globe; (2) Tyson did not in fact have sufficient safety protocols to protect its employees in its facilities; (3) as a result, Tyson employees contracted and spread the coronavirus within the facilities; (4) as a result of the foregoing, Tyson would face negative impact to its production, including complete shutdowns of certain facilities; (5) due to the failure to protect its employees, Tyson would suffer financial harm related to its lowered production; and (6) as a result, defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Tyson class action, go to http://www.rosenlegal.com/cases-register-2022.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com cases@rosenlegal.com www.rosenlegal.com

  • WORKHORSE GROUP ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Workhorse Group, Inc. and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm

    Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of investors that purchased Workhorse Group, Inc. (NASDAQ: WKHS) securities between July 7, 2020 and February 23, 2021, inclusive (the "Class Period"). Investors have until May 7, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

  • English Website of the Tokushima International Consumer’s Forum 2020 Opens

    English website of the Tokushima International Consumer’s Forum 2020 opens